Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Recruiting × pertuzumab × Clear all

Phase

Phase 2 25 Phase 3 14 Phase 1/2 5 Phase 2/3 2 Phase 1 1

Status

Completed 10 Terminated 4 Active not recruiting 4 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

Cyclophosphamide 102 Specimen Handling 97 pembrolizumab 94 Magnetic Resonance Spectroscopy 84 fludarabine 81 Biopsy 72 Injections 40 venetoclax 37 Bevacizumab 37 Radiotherapy 32 Paclitaxel 32 Nivolumab 31 Cetuximab 31 Carboplatin 31 fludarabine phosphate 29 Fluorouracil 29 Cisplatin 29 Gemcitabine 28 Oxaliplatin 25 Immunotherapy, Adoptive 23 Leucovorin 21 Azacitidine 21 Radiation 20 130-nm albumin-bound paclitaxel 19 tislelizumab 18 atezolizumab 18 Ipilimumab 18 Cytarabine 18 Temozolomide 17 Leukapheresis 17

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06162559 2024-01-11

TRAIN-4

The Netherlands Cancer Institute

Phase 1 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡